http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110827995-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40
filingDate 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110827995-B
titleOfInvention A characterization method of secondary metabolite chromatographic and mass spectrometry fingerprints of A.
abstract The invention relates to the technical field of traditional Chinese medicine drug analysis, in particular to a method for characterizing secondary metabolite chromatography and mass spectrometry fingerprints of a medicinal material of Radix Nutria. The present invention adopts UPLC to establish the fingerprint spectrum of the whole components of the medicinal materials of Nasturtica chinensis, and adopts the combined technology of UPLC and DAD/QTOF-MS/MS to perform the on-line rapid component qualitative analysis of the fingerprints of the whole components of the medicinal materials of Rhododendron chinensis and the compounds. Identify and form the best phenotype of the chemical substances in the specific natural environment of the natural medicinal material. The beneficial effects of the invention are as follows: the fingerprint spectrum method of the whole components of the medicinal material of Radix japonica is simple to operate, the peak capacity is large, and the precision, reproducibility and stability are all good, the chromatographic peak separation degree is good, the analysis time is short, and the analysis time is short. The efficiency and sensitivity are high; the best phenotype of the chemical substances in the specific natural environment of the natural medicinal material is formed, which solves the problems of confusion in the application of the base source of the naked flower and the inability to characterize the authentic medicinal material in the market.
priorityDate 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415969580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421344630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 32.